BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28263844)

  • 1. A High-Throughput Bioluminescent Assay to Monitor the Deamidation of Asparagine and Isomerization of Aspartate Residues in Therapeutic Proteins and Antibodies.
    Hsiao K; Alves J; Patel R; Adams M; Nashine V; Goueli S
    J Pharm Sci; 2017 Jun; 106(6):1528-1537. PubMed ID: 28263844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent highly sensitive characterization of asparagine deamidation and aspartic acid isomerization by sheathless CZE-ESI-MS/MS.
    Gahoual R; Beck A; François YN; Leize-Wagner E
    J Mass Spectrom; 2016 Feb; 51(2):150-8. PubMed ID: 26889931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
    Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
    Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fluorescence-Based High-Throughput Coupled Enzymatic Assay for Quantitation of Isoaspartate in Proteins and Peptides.
    Puri A; Quan Y; Narang AS; Adams M; Gandhi R; Nashine VC
    AAPS PharmSciTech; 2017 Apr; 18(3):803-808. PubMed ID: 27342117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11.
    Zhang W; Czupryn JM; Boyle PT; Amari J
    Pharm Res; 2002 Aug; 19(8):1223-31. PubMed ID: 12240950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.
    Wakankar AA; Borchardt RT
    J Pharm Sci; 2006 Nov; 95(11):2321-36. PubMed ID: 16960822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
    Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
    PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
    Terashima I; Koga A; Nagai H
    Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.
    Liu S; Moulton KR; Auclair JR; Zhou ZS
    Amino Acids; 2016 Apr; 48(4):1059-1067. PubMed ID: 26748652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting aspartate isomerization and backbone cleavage after aspartate in intact proteins by NMR spectroscopy.
    Hinterholzer A; Stanojlovic V; Regl C; Huber CG; Cabrele C; Schubert M
    J Biomol NMR; 2021 Jan; 75(1):71-82. PubMed ID: 33475951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
    Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
    Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants.
    DiCara DM; Andersen N; Chan R; Ernst JA; Ayalon G; Lazar GA; Agard NJ; Hilderbrand A; Hötzel I
    MAbs; 2018 Oct; 10(7):1073-1083. PubMed ID: 30130444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing deamidation in therapeutic immunoglobulin gamma (IgG1) by 'bottom-up' mass spectrometry with electron transfer dissociation.
    Mukherjee R; Adhikary L; Khedkar A; Iyer H
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):879-84. PubMed ID: 20196189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine deamidation dependence on buffer type, pH, and temperature.
    Pace AL; Wong RL; Zhang YT; Kao YH; Wang YJ
    J Pharm Sci; 2013 Jun; 102(6):1712-1723. PubMed ID: 23568760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput detection of deamidation using S-(5'-adenosyl)-l-homocysteine hydrolase and a fluorogenic reagent.
    Murphy BM; Ozumerzifon TJ; Henry CS; Manning MC
    J Pharm Biomed Anal; 2018 Jul; 156():323-327. PubMed ID: 29747122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoaspartate in peptides and proteins: formation, significance, and analysis.
    Aswad DW; Paranandi MV; Schurter BT
    J Pharm Biomed Anal; 2000 Jan; 21(6):1129-36. PubMed ID: 10708396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of deamidation and isomerization in β2-microglobulin by 18O labeling.
    Fukuda M; Takao T
    Anal Chem; 2012 Dec; 84(23):10388-94. PubMed ID: 23126476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonenzymatic Posttranslational Modifications and Peptide Cleavages Observed in Peptide Epimers.
    Long CC; Antevska A; Mast DH; Okyem S; Sweedler JV; Do TD
    J Am Soc Mass Spectrom; 2023 Sep; 34(9):1898-1907. PubMed ID: 37102735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.